摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Ethyl 3-[5-[3-chloro-5-[(1-methylpyrazol-3-yl)carbamoyl]phenoxy]pyrazin-2-yl]-1,2,4-oxadiazole-5-carboxylate | 1310808-76-4

中文名称
——
中文别名
——
英文名称
Ethyl 3-[5-[3-chloro-5-[(1-methylpyrazol-3-yl)carbamoyl]phenoxy]pyrazin-2-yl]-1,2,4-oxadiazole-5-carboxylate
英文别名
——
Ethyl 3-[5-[3-chloro-5-[(1-methylpyrazol-3-yl)carbamoyl]phenoxy]pyrazin-2-yl]-1,2,4-oxadiazole-5-carboxylate化学式
CAS
1310808-76-4
化学式
C20H16ClN7O5
mdl
——
分子量
469.844
InChiKey
LCIUSXANQOGKCG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    33
  • 可旋转键数:
    8
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.15
  • 拓扑面积:
    147
  • 氢给体数:
    1
  • 氢受体数:
    10

文献信息

  • BENZAMIDE COMPOUND
    申请人:Hayakawa Masahiko
    公开号:US20120277208A1
    公开(公告)日:2012-11-01
    [Problem]A compound which is useful as a GK activator is provided. [Means for Solution] The present inventors have conducted studies on compounds having a GK activating action, which are promising as active ingredients of pharmaceutical compositions for the treatment of diabetes, type 2 diabetes mellitus, obesity, metabolic syndrome and related diseases caused by the aforementioned diseases, and as a result, they have confirmed that a benzamide compound of the present invention has an excellent GK activating action, thereby completing the present invention. That is, the benzamide compound of the present invention has a GK activating action and can be used as an agent for preventing and/or treating diabetes, type 2 diabetes mellitus, obesity, metabolic syndrome, and related diseases caused by the aforementioned diseases.
    【问题】提供一种作为GK激活剂有用的化合物。【解决方法】本发明人对具有GK激活作用的化合物进行了研究,这些化合物有望成为治疗糖尿病、2型糖尿病、肥胖症、代谢综合征以及由上述疾病引起的相关疾病的药物组合物的活性成分,结果确认本发明的苯甲酰胺化合物具有出色的GK激活作用,从而完成了本发明。也就是说,本发明的苯甲酰胺化合物具有GK激活作用,可用作预防和/或治疗糖尿病、2型糖尿病、肥胖症、代谢综合征以及由上述疾病引起的相关疾病的药剂。
查看更多